Trinity Biotech reported $14.31M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Bio-Rad Laboratories USD 592.1M 101.1M Mar/2026
EDAP TMS EUR 15.42M 1.54M Mar/2026
J&J USD 24.1B 500M Mar/2026
Mesa Laboratories USD 62.84M 5.01M Dec/2024
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.37M 30K Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Siemens EUR 19.76B 620M Mar/2026
Surmodics USD 29.57M 355K Jun/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Tosoh JPY 263.84B 6.9B Mar/2026
Trinity Biotech USD 14.31M 1.55M Sep/2025
Veracyte USD 139.07M 1.53M Mar/2026